Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension

Pediatric Pulmonology

Volumn 43, Issue 3, 2008, Pages 224-235

  Hoskote, Aparna U ^a,c   Castle, Rosemary A ^a,b   Hoo, Ah Fong ^a,b   Lum, Sooky ^b   Ranganathan, Sarath C ^b   Mok, Quen Q ^a   Stocks, Janet ^b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Great Ormond Street Hospital for Children NHS Trust   (United Kingdom)

Author keywords

ECMO; High frequency ventilation; Newborn; Persistent foetal circulation; Pulmonary vasodilator

Indexed keywords

NITRIC OXIDE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXPIRATORY FLOW; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MORBIDITY; NEWBORN; PERSISTENT PULMONARY HYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME; WHEEZING;

COHORT STUDIES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FOLLOW-UP STUDIES; HIGH-FREQUENCY VENTILATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MAXIMAL EXPIRATORY FLOW RATE; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATORY THERAPY;

EID: 40649091638     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20733     Document Type: Article

References (60)

1. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000;342:469-474.
2. Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2001;4: CD000399
3. Finer NN, Sun JW, Rich W, Knodel E, Barrington KJ. Randomized, prospective study of low-dose versus high-dose inhaled nitric oxide in the neonate with hypoxic respiratory failure. Pediatrics 2001;108:949-955.
4. Kinsella JP, Abman SH. Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia. J Pediatr 2000;136:717-726.
5. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, deLemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997;131:55-62.
6. Roberts JD, Jr., Fineman JR, Morin FC III, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 1997;336:605-610.
7. Christou H, Van Marter LJ, Wessel DL, Allred EN, Kane JW, Thompson JE, Stark AR, Kourembanas S. Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med 2000;28:3722-3727.
8. Hoffman GM, Ross GA, Day SE, Rice TB, Nelin LD. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 1997;25:352-359.
9. Field D, Elbourne D, Hardy P, Fenton AC, Ahluwalia J, Halliday HL, Subhedar N, Heinonen K, Aikio O, Grieve R, Truesdale A, Tomlin K, Normand C, Stocks J. Neonatal ventilation with inhaled nitric oxide vs. ventilatory support without inhaled nitric oxide for infants with severe respiratory failure born at or near term: the INNOVO multicentre randomised controlled trial. Neonatology 2007;91:73-82.
10. Kinsella JP, Abman SH. High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: Nitric Oxide Study Group. Chest 1998;114:100S.
11. Mercier JC, Lacaze T, Storme L, Roze JC, Dinh-Xuan AT, Dehan M. Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. French Paediatric Study Group of Inhaled NO. Eur J Pediatr 1998;157:747-752.
12. Hoehn T, Krause M, Hentschel R. High-frequency ventilation augments the effect of inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Eur Respir J 1998;11: 234-238.
13. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, Kerecman JD, Albertine KH, Winter VT, Coalson JJ, Crapo JD, Grubb PH, Shaul PW. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 2005;288:L450-L459.
14. Cotton RB, Sundell HW, Zeldin DC, Morrow JD, Roberts LJ, Hazinski TA, Law AB, Steele S. Inhaled nitric oxide attenuates hyperoxic lung injury in lambs. Pediatr Res 2006;59:142-146.
15. Bland RD, Albertine KH, Carlton DP, MacRitchie AJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 2005;172: 899-906.
16. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006;355:343-353.
17. Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, Walsh-Sukys MC, McCaffrey MJ, Cornfield DN, Bhutani VK, Cutter GR, Baier M, Abman SH. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet 1999;354:1061-1065.
18. Dani C, Bertini G, Pezzati M, Filippi L, Cecchi A, Rubaltelli FF. Inhaled nitric oxide in very preterm infants with severe respiratory distress syndrome. Acta Paediatr 2006;95:1116-1123.
19. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003;349:2099-2107.
20. Tanaka Y, Hayashi T, Kitajima H, Sumi K, Fujimura M. Inhaled nitric oxide therapy decreases the risk of cerebral palsy in preterm infants with persistent pulmonary hypertension of the newborn. Pediatrics 2007;119:1159-1164.
21. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SH. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006;355:354-364.
22. Stark AR. Inhaled NO for preterm infants-getting to yes? N Engl J Med 2006;355:404-406.
23. Martin RJ, Walsh MC. Inhaled nitric oxide for preterm infants-who benefits? N Engl J Med 2005;353:82-84.
24. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2006;1: CD000509
25. Weinberger B, Laskin DL, Heck DE, Laskin JD. The toxicology of inhaled nitric oxide. Toxicol Sci 2001;59:5-16.
26. Barth PJ, Muller B, Wagner U, Bittinger A. Quantitative analysis of parenchymal and vascular alterations in NO2-induced lung injury in rats. Eur Respir J 1995;8:1115-1121.
27. McElroy MC, Pittet JF, Allen L, Wiener-Kronish JP, Dobbs LG. Biochemical detection of type I cell damage after nitrogen dioxide-induced lung injury in rats. Am J Physiol 1997;273: L1228-1234.
28. Rosenberg AA. Outcome in term infants treated with inhaled nitric oxide. J Pediatr 2002;140:284-287.
29. Rosenberg AA, Kennaugh JM, Moreland SG, Fashaw LM, Hale KA, Torielli FM, Abman SH, Kinsella JP. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr 1997;131:70-75.
30. Dobyns EL, Griebel J, Kinsella JP, Abman SH, Accurso FJ. Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatr Pulmonol 1999; 28:24-30.
31. UK Collaborative ECMO Trail Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996;348:75-82.
32. The collaborative UK ECMO. (Extracorporeal Membrane Oxygenation) trial: follow-up to 1 year of age. Pediatrics 1998; 101:E1.
33. Bennett CC, Johnson A, Field DJ, Elbourne D. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet 2001;357:1094-1096.
34. McNally H, Bennett CC, Elbourne D, Field DJ. United Kingdom collaborative randomized trial of neonatal extracorporeal membrane oxygenation: follow-up to age 7 years. Pediatrics 2006;117: e845-e854.
35. Beardsmore C, Dundas I, Poole K, Enock K, Stocks J. Respiratory function in survivors of the United Kingdom Extracorporeal Membrane Oxygenation Trial. Am J Respir Crit Care Med 2000; 161:1129-1135.
36. Greenspan JS, Antunes MJ, Holt WJ, McElwee D, Cullen JA, Spitzer AR. Pulmonary sequelae in infants treated with extracorporeal membrane oxygenation. Pediatr Pulmonol 1997;23: 31-38.
37. Dundas I, Beardsmore C, Wellman T, Stocks J. A collaborative study of infant respiratory function testing. Eur Respir J 1998;12: 944-953.
38. Sly PD, Tepper R, Henschen M, Gappa M, Stocks J. Tidal forced expirations. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J 2000;16:741-748.
39. Hoo AF, Dezateux C, Hanrahan JP, Cole TJ, Tepper RS, Stocks J. Sex-specific prediction equations for Vmax(FRC) in infancy: a multicenter collaborative study. Am J Respir Crit Care Med 2002;165:1084-1092.
40. Stocks J. Pulmonary function tests in infants and young children. In: Chernick V, Boat TF, Wilmott RW, Bush A, editors. Kendig's disorders of the respiratory tract in children. 7th edition. Philadelphia: Elsevier; 2006. pp. 129-167.
41. Ranganathan SC, Hoo AF, Lum SY, Goetz I, Castle RA, Stocks J. Exploring the relationship between forced maximal flow at functional residual capacity and parameters of forced expiration from raised lung volume in healthy infants. Pediatr Pulmonol 2002;33:419-428.
42. Dezateux C, Stocks J, Dundas I, Fletcher ME. Impaired airway function and wheezing in infancy: the influence of maternal smoking and a genetic predisposition to asthma. Am J Respir Crit Care Med 1999;159:403-410.
43. Dezateux C, Stocks J, Wade AM, Dundas I, Fletcher ME. Airway function at one year: association with premorbid airway function, wheezing, and maternal smoking. Thorax 2001;56:680-686.
44. Latzin P, Frey U, Roiha HL, Baldwin DN, Regamey N, Strippoli MP, Zwahlen M, Kuehni CE. Prospectively assessed incidence, severity, and determinants of respiratory symptoms in the first year of life. Pediatr Pulmonol 2007;42:41-50.
45. Dezateux C, Lum S, Hoo AF, Hawdon J, Costeloe K, Stocks J. Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis. Thorax 2004;59:60-66.
46. Hoo AF, Stocks J, Lum S, Wade AM, Castle RA, Costeloe KL, Dezateux C. Development of lung function in early life: influence of birth weight in infants of nonsmokers. Am J Respir Crit Care Med 2004;170:527-533.
47. Stocks J, Dezateux C. The effect of parental smoking on lung function and development during infancy. Respirology 2003;8: 266-285.
48. Thomas MR, Rafferty GF, Limb ES, Peacock JL, Calvert SA, Marlow N, Milner AD, Greenough A. Pulmonary function at follow-up of very preterm infants from the United Kingdom oscillation study. Am J Respir Crit Care Med 2004;169:868-872.
49. Hoo AF, Henschen M, Dezateux C, Costeloe K, Stocks J. Respiratory function among preterm infants whose mothers smoked during pregnancy. Am J Respir Crit Care Med 1998;158: 700-705.
50. Bahrami KR, Van Meurs KP. ECMO for neonatal respiratory failure. Semin Perinatol 2005;29:15-23.
51. Hintz SR, Benitz WE, Colby CE, Sheehan AM, Rycus P, Van Meurs KP. Utilization and outcomes of neonatal cardiac extracorporeal life support: 1996-2000. Pediatr Crit Care Med 2005;6: 33-38.
52. Lipkin PH, Davidson D, Spivak L, Straube R, Rhines J, Chang CT. Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide. J Pediatr 2002;140:306-310.
53. Ichiba H, Matsunami S, Itoh F, Ueda T, Ohsasa Y, Yamano T. Three-year follow up of term and near-term infants treated with inhaled nitric oxide. Pediatr Int 2003;45:290-293.
54. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 2000;136:611-617.
55. Hallman M, Bry K, Turbow R, Waffarn F, Lappalainen U. Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure. J Pediatr 1998;132:827-829.
56. Boykin AR, Quivers ES, Wagenhoffer KL, Sable CA, Chaney HR, Glass P, Bahrami KR, Short BL. Cardiopulmonary outcome of neonatal extracorporeal membrane oxygenation at ages 10-15 years. Crit Care Med 2003;31:2380-2384.
57. Hamutcu R, Nield TA, Garg M, Keens TG, Platzker AC. Long-term pulmonary sequelae in children who were treated with extracorporeal membrane oxygenation for neonatal respiratory failure. Pediatrics 2004;114:1292-1296.
58. Hoo AF, Dezateux C, Henschen M, Costeloe K, Stocks J. Development of airway function in infancy after preterm delivery. J Pediatr 2002;141:652-658.
59. Turner SW, Palmer LJ, Rye PJ, Gibson NA, Judge PK, Cox M, Young S, Goldblatt J, Landau LI, Le Souef PN. The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med 2004;169:921-927.
60. Filippone M, Sartor M, Zacchello F, Baraldi E. Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age. Lancet 2003;361:753-754.